Named Patient Supply

The supply of unlicensed medicines is strictly regulated. They can be supplied on a “named patient” basis where:-

• They have yet to gain a marketing authorisation for use in a specific disease area
• They have yet to be licensed by the regulatory authority
• They are classified as an orphan drug

Alan Pharmaceuticals has over 12 years experience in managing the supply of unlicensed medicines. Our named-patient programmes are tailored to meet the requirements of each of our clients. We offer:-

• Market intelligence and pre -marketing data which can help support the approval of a drug
• The commercial opportunity to increase sales prior to approval and help to uplift sales at launch
• Pharmacovigilance systems that enable us to manage a product recall or quality control a situation
• Detailed data recording to manage traceability and counterfeit concerns

Our Expertise

• Our in-house pharmacists are able to offer pharmacological and clinical advice.
• Our in-house lawyers ensure compliance with all regulatory requirements.
• We operate in the following languages: English, French, Italian, Russian and Spanish.
• We routinely export pharmaceuticals to the developing world, and are experienced in handling all manner of customs and other regulatory requirements.
• We offer any combination of freight options by road, sea and air, and are able to meet all storage requirements including “Cold Storage” “Fragile” and “Hazardous”.